Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Remegen (9995 HK)
Watchlist
211
Analysis
Health Care
•
China
RemeGen Co., Ltd. operates biotechnology businesses. The Company develops therapeutic antibody drugs such as antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies. RemeGen provides solutions autoimmune diseases, tumor diseases, and ophthalmic diseases.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
06 Feb 2025 19:46
List Of Directors And Their Roles And Functions
Attachment
Exchange Announcement •
06 Feb 2025 19:41
Announcement On The Resignation Of An Executive Director
Attachment
Exchange Announcement •
16 Jan 2025 18:50
Inside Information-Estimated 2024 Annual Results
Attachment
Exchange Announcement •
10 Jan 2025 20:56
List Of Directors And Their Roles And Functions
Attachment
Exchange Announcement •
10 Jan 2025 20:48
Poll Results Of The 2025 First Extraordinary General Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.46.12
x